fb tracking

Product Recalls: August 19, 2026-September 16, 2026

Health Letter, October 2026

Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.

For Class 1 recalls, there is a potential for serious injury or death.

For Class 2 recalls, there is a potential for serious adverse events but a lower chance of the drug causing serious injury or death than in a Class 1 recall.

CLASS I

 

CLASS II

acamprosate calcium, delayed-release tablets, 333 mg, 180-tablet bottles. Manufactured for: Mylan Pharmaceuticals Inc. Lot #: 3227809, exp. date: 10/2026.

carbamazepine tablets, 200 mg, 1,000-count bottles. Manufactured by: Taro Pharmaceutical Industries Ltd. Lot #: AD94033, exp. date: 5/31/2028; Lot #: GS067429 or GS068091, exp. date: 5/31/2028; Lot #: GS067430 or GS068090, exp. date: 5/31/2028.

levothyroxine sodium tablets; 25, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200 or 300 mcg; 90- or 1,000-count bottles. Manufactured for: Accord Healthcare, Inc. Manufactured by: Intas Pharmaceuticals Limited. Lot #: D2401927 or D2401833, exp. date: 08/31/2026; Lot #: D2402551 or D2402552, exp. date: 11/30/2026; Lot #: D2500220, exp. date: 12/31/2026; Lot #: D2500223, exp. date: 01/31/2027; Lot #: D2401834 or D2401982, exp. date: 08/31/2026; Lot #: D2402584, D2402585, D2402586, D2402588, D2402587 or D2402589, exp. date: 11/30/2026; Lot #: D2402016 or D2402017, exp. date: 08/31/2026; Lot #: D2401813 or D2401814, exp. date: 08/31/2026; Lot #: D2500200 or D2500219, exp. date: 12/31/2026; Lot #: D2402186, exp. date: 09/30/2026; Lot #: D2402019, exp. date: 08/31/2026; Lot #: D2402094, exp. date: 09/30/2026; Lot #: D2500022, D2500023 or D2500021, exp. date: 12/31/2026; Lot #: D2402443, D2402444 or D2402445, exp. date: 10/31/2026; Lot #: D2401983, exp. date: 08/31/2026; Lot #: D2402640 or D2402641, exp. date: 11/30/2026; Lot #: D2500224, exp. date: 01/31/2027; Lot # D2402125, D2402126 or D2402127, exp. date: 09/30/2026; Lot #: D2402523 or D2402524, exp. date: 11/30/2026; Lot #: D2402195, D2402196 or D2402197, exp. date: 09/30/2026; Lot #: D2402642, exp. date: 11/30/202; Lot #: D2401832, exp. date: 08/31/2026; Lot #: D2402525, D2402527, D2402526, D2402644 or D2402643, exp. date: 11/30/2026; Lot #: D2402430 or D2402431, exp. date: 10/31/2026; Lot #: D2402432, exp. date: 10/31/2026; Lot #: D2500180, exp. date: 12/31/2026; Lot #: D2402337, exp. date: 10/31/2026.

Paxil CR, paroxetine, extended-release tablets, 37.5 mg, 30-count bottle. Manufactured by: Apotex Inc. Lot #: TY9494, exp. date: 05/31/2027.

prasugrel tablets, 10 mg, 30 tablets per bottle. Manufactured for: Mylan Pharmaceuticals Inc. or Marketed by: GSMS, Incorporated. Lot #: 3225272, exp. date: September 30, 2026; Lot #: GS062298, exp. date: 09/30/2026.

ramipril capsules, 10 mg, 100- or 500-capsule bottle. Manufactured for: Exelan Pharmaceuticals, Inc. Manufactured by: West-Ward Columbus Inc. Lot #: AC5470A, exp. date: July 2027; Lot #: AC5470B, exp. date: July 2027.

traZODone hydrochloride tablets, 50 mg, 100 tablets. Manufactured by: Pliva Hrvatska d.o.o. Lot #: 1394026, exp. date: 02/2028.

For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.

CONSUMER PRODUCTS

For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.